Vaccinex (NASDAQ:VCNX) Shares Down 3.4% – Here’s Why

Vaccinex, Inc. (NASDAQ:VCNX) shares fell 3.4% during trading on Tuesday . The company traded as low as $1.02 and last traded at $1.06. 4,064 shares were traded during trading, an increase of 1% from the average session volume of 4,016 shares. The stock had previously closed at $1.10.

Vaccinex Price Performance

The stock has a fifty day moving average of $2.73 and a 200 day moving average of $4.20. The firm has a market capitalization of $2.47 million, a P/E ratio of -0.02 and a beta of 1.10.

Institutional Investors Weigh In On Vaccinex

A hedge fund recently raised its stake in Vaccinex stock. Point72 Asset Management L.P. boosted its position in Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 166,000 shares of the company’s stock after acquiring an additional 49,454 shares during the period. Point72 Asset Management L.P. owned 9.60% of Vaccinex worth $564,000 as of its most recent SEC filing. Institutional investors own 50.11% of the company’s stock.

Vaccinex Company Profile

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.